Doctors & patients are saying about 'A-Fib.com'...


"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."

Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN

"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."

Jill and Steve Douglas, East Troy, WI 

“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP. 

Faye Spencer, Boise, ID, April 2017

“I think your site has helped a lot of patients.”

Dr. Hugh G. Calkins, MD  Johns Hopkins,
Baltimore, MD


Doctors & patients are saying about 'Beat Your A-Fib'...


"If I had [your book] 10 years ago, it would have saved me 8 years of hell.”

Roy Salmon, Patient, A-Fib Free,
Adelaide, Australia

"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."

Pierre Jaïs, M.D. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France

"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."

Dr. Wilber Su,
Cavanaugh Heart Center, 
Phoenix, AZ

"...masterful. You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. This is not an easy thing to do, but you have been very, very successful at it."

Ira David Levin, heart patient, 
Rome, Italy

"Within the pages of Beat Your A-Fib, Dr. Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation."

Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA


Women with A-Fib: Mother Nature and Gender Bias—Or—Get Thee to an EP ASAP

Research on Atrial Fibrillation

by Patti J. Ryan, August 2015

Several studies have established that the symptoms and consequences of A-Fib are more profoundly felt in women.

Mother Nature and A-Fib Symptoms in Women

Females tend to develop A-Fib at a later age than men. They are also more likely to seek medical attention, are usually more symptomatic, and have higher heart rates. A-Fib tends to affect their physical quality of life more severely. While women’s physical pain is not taken nearly as seriously. Women suffer more from A-Fib related anxiety which in turn increases the risk of being misdiagnosed as panic disorders. Women are misdiagnosed more often than men. Women’s bodies are poorly understood as a result of less inclusion in research and education.

Women have a lower incidence of A-Fib than men. While men as a group develop A-Fib twice as often as women, there are twice as many females as males in the age group with the highest percentage of A-Fib, mainly because women live longer than men. The risk of A-Fib is higher with increasing pregnancies. Women have increased atrial fibrosis and a higher incidence of non-pulmonary vein triggers.

Cardiovascular mortality rates are 2.5-fold greater for women with A-Fib. Women have a 4.6-fold higher rate of stroke. Post menopausal women are especially at risk for a stroke. The estrogen deficiency that comes with menopause causes a weakness in the arterial walls and an increase in proinflammatory molecules in the brain called cytokines. A-Fib is the most frequent cause of disabling stroke in elderly females.

Remember: you don’t have to live with A-Fib! Seek your cure.

What can you do about it? As a female with A-Fib, you may have more symptoms, quality of life issues, and are at greater risk of an A-Fib-related stroke. But you don’t have to live with A-Fib. As soon as practical, get a referral to a heart rhythm specialist (an Electrophysiologist (EP)—a cardiologist with a specialty in electrophysiology). Early diagnosis means less damage to your heart and more treatment options.

Drug Therapies for Women with A-Fib and Risk of Stroke

Women fail more antiarrhythmic drugs therapies than men. Women don’t do well on some antiarrhythmic drugs (estrogen may prolong the QT interval). (Women have a longer QT interval than men.) When treated with antiarrhythmic drugs, women are more likely to have life-threatening adverse events. Women with A-Fib are less likely to receive anticoagulation.

Antiarrhythmic drug therapy in women with hypertension is associated with more major cardiovascular events. (Some research indicates that women may have more hypertension than men, 55.2% vs 40%).

What this means to patients: Drugs don’t cure A-Fib but merely keep it at bay,” says heart rhythm specialist, Dr. Dhiraj Gupta. Antiarrhythmic drugs only work for about 50% of patients, and often stop working after a period of time. Many can’t tolerate the side effects.

Don’t spend a year in A-Fib trying different medications or combinations of medications only to find none work for you. In addition, anticoagulants, like warfarin, for your increased stroke risk, have their own health risks. Don’t live a life on medication. Seek your cure.

Differences in Catheter Ablation for Females with A-Fib

Women, in general, have smaller cardiac chambers so that catheter manipulation is more of a challenge (40.6 mm on average for women vs 44.6 mm for men). (However, since research data shows there is a significant delay in referral for ablation in women, it is feasible that they may have larger left atrial sizes due to remodeling, making this a moot point.)

Run, don’t walk to the best heart rhythm specialist (an electrophysiologist) you can find. 

Females have more non-PV triggers and have lower ablation success rates. Around five times as many males undergo catheter ablation than females.

Females tend to have more ablation complications like pericardial tamponade, vascular complications, and bleeding. Women also have worse left atrial appendage function, which may contribute to the higher risk of s troke.

What can you do about it? Don’t delay. “Run, don’t walk” to the best heart rhythm specialist (an electrophysiologist) you can find, advises former A-Fib patient Sheri Weber. A-Fib is a progressive disease. Consult an EP after your diagnosis. Don’t wait for your A-Fib to get worse. (A-Fib rarely gets better.)

Gender Bias Also Plays a Role

Women are referred to A-Fib specialists three times less often than men. Men with A-Fib are managed more aggressively (such as more cardioversions) prior to seeking a catheter ablation.

Women often have developed a larger left atrium because of being referred to EPs later in their treatment plan than men (60 months for females vs 47 months for males).

Women are referred to A-Fib specialists three times less often than men.

Women are referred for catheter ablation less frequently and later into their treatment plan than men. When referred, they are older on average than men (61.6 years old vs 56.9 years old for men).

Consequently, they have more complex symptoms, and their procedure success rate is lower with more complications.

What can you do about it? When you go to your GP or cardiologist with your A-Fib symptoms or complaints, anticipate gender bias! Don’t let it deter you. A-Fib is a progressive disease. Don’t waste time. Don’t let your A-Fib worsen over time by remodeling or enlarging your heart. Request a referral to a heart rhythm specialist―an electrophysiologist (EP). Until you consult an EP, you may not be getting the best and most up-to-date A-Fib treatment advice. You deserve nothing less.

Don’t just take your meds and get used to being in A-Fib.

Why is there Gender Bias in the Treatment of Women with A-Fib?

In many cultures and societies, doctors are more conservative in their treatment of women with A-Fib. Some doctors, concerned with safety, may be reluctant to perform or recommend any invasive procedures in women.

Social and family pressures may delay medical consultation and treatment (“I can’t be sick. My family needs me.”) Access to health care may be limited for some women.

And, of course, there’s plain ol’ bias by male doctors against female patients. “Your symptoms are all in your mind.” or “Just take your meds and get used to being in A-Fib.” (These are actual quotes from A-Fib.com readers about their doctors’ advice.)

What can you do about it? Be prepared for your doctor appointment with a list of questions or concerns. Don’t leave until you have answers. Don’t be afraid to ‘fire’ your doctor. Get a second, or third opinion. Find a doctor who will partner with you to find your cure or best outcome. (For help, use the Finding the Right Doctor for You resources on A-Fib.com.)

Good News: EPs Less Likely to Have Gender Bias

Research indicates female gender bias tends to disappear when a woman sees an electrophysiologist (EP), particularly concerning catheter ablation. This suggests that treatment bias may be more at the primary care level, i.e., your GP or general cardiologist.

What this means to patients: It’s reassuring to be in the care of someone who regularly treats A-Fib patients. A-Fib is an electrical problem. Don’t waste you time. Don’t settle for just ‘managing’ your A-Fib. See a heart rhythm specialist, an electrophysiologist, a cardiologist who specializes in the electrical function of your heart. An EP will discuss all your treatment options. EPs want to free you from the burden of A-Fib.


Patti J Ryan, writer and editor, a-Fib.com

About the Author: Patti J. Ryan is editor of A-Fib.com and regularly contributes her writing and graphics expertise.  She is also publisher of Beat Your A-Fib: The Essential Guide to Finding Your Cure by Steve S. Ryan, PhD (BeatYourA-Fib.com), an Amazon.com Top 100 Seller in two health-related categories.

References for this article
Patel, D. et al. Atrial Fibrillation Catheter Ablation in Females. Expert Rev Cardiovasc Ther. 2011;9(11):1391-1395. http://www.medscape.com/viewarticle/753555Forleo, G. et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 9, 613-620 (2007). Last accessed Aug 13, 2015. http://europace.oxfordjournals.org/content/9/8/613.short

Roten L, et al. Gender differences in patients referred for atrial fibrillation management to a tertiary center. PACE 32, 622–626 (2009). Specifically examines the proportion of males to females referred for ablation in a specialized outpatient clinic. Women were referred three-times less frequently than males to the clinic.

Friberg J, et al. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am. J. Cardiol. 94, 889–894 (2004).

Patel D, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 7, 167–172 (2010). The largest study to date that evaluates the safety and efficacy of catheter ablation in females.

Feinberg WM, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 155, 469–473 (1995).

Humphries KH, et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 103, 2365–2370 (2001). Evaluated the effects of gender on atrial fibrillation presentation, management and outcomes.

Dagres N, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J. Am. Coll. Cardiol. 49, 572–577 (2007).

Fang MC, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the Anticoagulation and Risk Factors In Atrial fibrillation (ATRIA) study. Circulation 112, 1687–1691 (2005).

Dagres N, et al. Significant gender-related differences in radiofrequency catheter ablation therapy. J. Am. Coll. Cardiol. 42, 1103–1107 (2003). Evaluated gender-related differences in catheter ablation in patients with accessory pathways and/or atrioventricular nodal re-entrant tachycardia.

Fuster V, et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 7, 257–354 (2006).

Shallenberger, Frank. The Connection Between Stroke and Frailty – And How to Avoid Both, Second Opinion, February 2020, Vol. XXX, No.2, p. 1.

Related Posts

Follow Us
facebook - A-Fib.comtwitter - A-Fib.comlinkedin - A-Fib.compinterest - A-Fib.comYouTube: A-Fib Can be Cured! - A-Fib.com

We Need You Help A-Fib.com be self-supporting-Use our link to Amazon  

A-Fib.com is a
501(c)(3) Nonprofit



Your support is needed. Every donation helps, even just $1.00.



A-Fib.com top rated by Healthline.com since 2014 

Home | The A-Fib Coach | Help Support A-Fib.com | A-Fib News Archive | Tell Us What You think | Press Room | GuideStar Seal | HON certification | Disclosures | Terms of Use | Privacy Policy